Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,306 | 34,339 | 36,881 | 40,979 | 43,174 |
| Marketable Securities | 9,940 | N/A | N/A | N/A | N/A |
| Receivables | N/A | N/A | N/A | 25 | 353 |
| Other current assets | 132 | 2,053 | 114 | 551 | 808 |
| TOTAL | $25,833 | $36,392 | $37,722 | $41,555 | $44,335 |
| Non-Current Assets | |||||
| PPE Net | 139 | 107 | 106 | 103 | 75 |
| Investments And Advances | 4,918 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,000 | 1,100 | 1,157 | 905 | 943 |
| TOTAL | $6,057 | $1,207 | $1,263 | $1,008 | $1,018 |
| Total Assets | $31,890 | $37,599 | $38,985 | $42,563 | $45,353 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 84 | 87 | 104 | 87 | 66 |
| Accounts payable and accrued liabilities | 949 | 2,118 | 561 | 789 | 978 |
| Other current liabilities | 2,081 | 1,587 | 1,403 | 2,193 | 848 |
| TOTAL | $3,410 | $4,217 | $2,553 | $3,577 | $2,451 |
| Non-Current Liabilities | |||||
| Long Term Debt | 542 | 561 | 591 | 620 | 647 |
| Deferred Revenues | 80 | 202 | 267 | 328 | 371 |
| Other Non-Current Liabilities | 921 | 993 | 1,025 | 820 | 867 |
| TOTAL | $1,463 | $1,554 | $1,615 | $1,440 | $1,513 |
| Total Liabilities | $4,873 | $5,771 | $4,168 | $5,017 | $3,964 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,883 | 11,883 | 11,883 | 11,880 | 11,877 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -20,926 | -20,926 | -7,035 | -7,035 | -7,035 |
| Other shareholders' equity | -8,504 | -3,387 | -13,981 | -10,783 | -6,171 |
| TOTAL | $27,017 | $31,828 | $34,818 | $37,545 | $41,389 |
| Total Liabilities And Equity | $31,890 | $37,599 | $38,985 | $42,562 | $45,353 |